{"schema_version":"secwatch.filing_event.v1","accession":"0000064803-25-000012","form_type":"8-K","ticker":"CVS","cik":"0000064803","company_name":"CVS HEALTH Corp","filed_at":"2025-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.038704+00:00","generated_at":"2026-05-23T01:24:24.349152+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"CVS Health Q1 Adj EPS $2.25 vs $1.31 YoY; raises FY25 Adj EPS guidance to $6.00-$6.20","bullets":["Total revenues $94.6B, up 7.0% YoY; GAAP diluted EPS $1.41, Adjusted EPS $2.25.","Operating income $3.374B vs $2.271B YoY; adjusted operating income $4.579B vs $2.957B.","Full-year 2025 guidance: GAAP diluted EPS revised to $4.23-$4.43 from $4.58-$4.83; Adjusted EPS raised to $6.00-$6.20 from $5.75-$6.00.","CVS Health to exit individual exchange business; introduces Aetna solutions and CVS Caremark GLP-1 formulary update.","Cash flow from ops $4.6B in Q1; FY25 CF guidance raised to ~$7.0B from ~$6.5B."],"urls":{"canonical":"https://secwatch.observer/filing/0000064803-25-000012","json":"https://secwatch.observer/filing/0000064803-25-000012.json","markdown":"https://secwatch.observer/filing/0000064803-25-000012.md","text":"https://secwatch.observer/filing/0000064803-25-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000012/0000064803-25-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000012/cvs-20250501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T01:24:24.349152+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}